Zerit and Metformin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zerit (stavudine) and Metformin (metformin hydrochloride). Common drug interactions include asocial behaviour among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Zerit and Metformin. It is created by eHealthMe based on reports of 53 people who take the same drugs from the FDA, and is updated regularly.

What is Zerit?

Zerit has active ingredients of stavudine. eHealthMe is studying from 9,912 Zerit users. Check the latest studies of Zerit.

What is Metformin?

Metformin has active ingredients of metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 465,354 Metformin users. Check the latest studies of Metformin.



On Jul, 14, 2026

53 people who take Zerit and Metformin together, and have interactions are studied.

Zerit and Metformin drug interactions.

What are the common drug interactions of Zerit and Metformin, by gender? *:

female:

  1. Asocial behaviour
  2. Blood cholesterol increased
  3. Blood creatinine increased
  4. Bone density decreased
  5. Bone pain
  6. Depressed mood
  7. Dizziness
  8. Dysstasia (difficulty in standing)
  9. Fatigue (feeling of tiredness)
  10. Foot fracture

male:

  1. Emotional distress
  2. Pain
  3. Nephrolithiasis (calculi in the kidneys)
  4. Depression
  5. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  6. Gait disturbance
  7. Hyperkalaemia (damage to or disease of the kidney)
  8. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  9. Impaired work ability
  10. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)

What are the common drug interactions of Zerit and Metformin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anal cancer stage 0
  2. B-cell lymphoma (blood cancer affecting b cells)
  3. Blood cholesterol increased
  4. Bone neoplasm malignant (cancer of bone)
  5. Colon cancer
  6. Drug ineffective
  7. Nausea (feeling of having an urge to vomit)
  8. Neoplasm malignant (cancer tumour)
  9. Neuropathy peripheral (surface nerve damage)
  10. Obesity (having too much body fat)

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Renal impairment (severely reduced kidney function)
  6. Renal failure (kidney dysfunction)
  7. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  8. Decreased activity
  9. Hyperkalaemia (damage to or disease of the kidney)
  10. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

50-59:

  1. Fear
  2. Fracture
  3. Glomerular filtration rate decreased
  4. Glomerulonephritis membranous (nephritis with inflammation of the capillary loops in the renal glomeruli)
  5. Hand fracture
  6. Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium)
  7. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
  8. Joint range of motion decreased (disease of joint movement)
  9. Lipodystrophy acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired)
  10. Nausea (feeling of having an urge to vomit)

60+:

  1. Emotional distress
  2. Pain
  3. Depression
  4. Gait disturbance
  5. Lactic acidosis (low ph in body tissues)
  6. Post-traumatic stress disorder
  7. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  8. Blood lactate dehydrogenase increased
  9. Blood ph decreased
  10. Blood pressure systolic decreased

What are the existing conditions these people have? *

  1. Hiv Infection: 45 people, 84.91%
  2. High Blood Pressure: 15 people, 28.30%
  3. High Blood Cholesterol: 13 people, 24.53%
  4. Depression: 10 people, 18.87%
  5. Pain: 7 people, 13.21%
  6. Neuralgia (pain in one or more nerves): 7 people, 13.21%
  7. Urinary Retention (the inability to completely or partially empty the bladder): 6 people, 11.32%
  8. Erection Problems: 6 people, 11.32%
  9. Cardiac Disorder: 5 people, 9.43%
  10. Insomnia (sleeplessness): 4 people, 7.55%

* Approximation only. Some reports may have incomplete information.

Do you take Zerit and Metformin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zerit and Metformin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zerit:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Metformin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zerit and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Metformin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on stavudine and metformin hydrochloride (the active ingredients of Zerit and Metformin, respectively), and Zerit and Metformin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: